Carcinoma, Advanced Metastatic

1 clinical trials · Condition

Record	Firm	Date
Phase I Trial of TGFB2-Antisense-GMCSF Gene Modified Autologous Tumor Cell (TAG) Vaccine for Advanced Cancer (NCT00684294)	Mary Crowley Medical Research Center	2008-05-27

Every clearance here is in the API, with alerts when new ones post.